Trimeric OX40-immunoglobulin fusion protein and methods of use
Compositions including a trimeric OX-40 fusion protein are disclosed. Also disclosed are methods for enhancing the immune response of a mammal to an antigen by engaging the OX-40 receptor on the surface of T-cells involving administering to the mammal a composition comprising a trimeric OX-40 fusion protein and a pharmaceutically acceptable carrier.
Earle A. Chiles Research Institute
Providence Health System (Seattle, WA)
Weinberg, Andrew D; Morris, Nicholas P.; and Romerdaue, Carmen, "Trimeric OX40-immunoglobulin fusion protein and methods of use" (2009). Technology Transfer - Patents. 34.